BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li T, Li X, Feng Y, Dong G, Wang Y, Yang J. The Role of Matrix Metalloproteinase-9 in Atherosclerotic Plaque Instability. Mediators Inflamm 2020;2020:3872367. [PMID: 33082709 DOI: 10.1155/2020/3872367] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu D, Ghani D, Wain J, Szeto WY, Laudanski K. Concomitant elevated serum levels of tenascin, MMP-9 and YKL-40, suggest ongoing remodeling of the heart up to 3 months after cardiac surgery after normalization of the revascularization markers. Eur J Med Res 2022;27:208. [PMID: 36271425 DOI: 10.1186/s40001-022-00831-8] [Reference Citation Analysis]
2 Marynenko T, Halenova T, Raksha N, Vovk T, Tyravska Y, Savchuk O, Falalyeyeva T, Fagoonee S, Abenavoli L, Ostapchenko L. Plasma matrix metalloproteinases (MMP-2 and MMP-9) as prognostic biomarkers in coronary heart disease. Minerva Biotechnol Biomol Res 2022;34. [DOI: 10.23736/s2724-542x.22.02906-6] [Reference Citation Analysis]
3 Damay VA, Setiawan, Lesmana R, Akbar MR, Lukito AA, Tarawan VM, Martha JW, Nugroho J, Xu B. Electronic Cigarette and Atherosclerosis: A Comprehensive Literature Review of Latest Evidences. International Journal of Vascular Medicine 2022;2022:1-11. [DOI: 10.1155/2022/4136811] [Reference Citation Analysis]
4 Badaras I, Laučytė-cibulskienė A. Vascular Aging and COVID-19. Angiology. [DOI: 10.1177/00033197221121007] [Reference Citation Analysis]
5 Wang Y, Chuang CY, Hawkins CL, Davies MJ. Activation and Inhibition of Human Matrix Metalloproteinase-9 (MMP9) by HOCl, Myeloperoxidase and Chloramines. Antioxidants (Basel) 2022;11:1616. [PMID: 36009335 DOI: 10.3390/antiox11081616] [Reference Citation Analysis]
6 Gkaliagkousi E, Lazaridis A, Dogan S, Fraenkel E, Tuna BG, Mozos I, Vukicevic M, Yalcin O, Gopcevic K. Theories and Molecular Basis of Vascular Aging: A Review of the Literature from VascAgeNet Group on Pathophysiological Mechanisms of Vascular Aging. IJMS 2022;23:8672. [DOI: 10.3390/ijms23158672] [Reference Citation Analysis]
7 Kicman A, Kołos J, Motyka J, Kulesza M, Niczyporuk M, Szmitkowski M, Ławicki S. The utility of metalloprotienase 9 (MMP-9) in diagnostics of ovarian cancer. Diagn Lab 2022;57:179-187. [DOI: 10.5604/01.3001.0015.8844] [Reference Citation Analysis]
8 Saleh S, George J, Kott KA, Meikle PJ, Figtree GA. The Translation and Commercialisation of Biomarkers for Cardiovascular Disease—A Review. Front Cardiovasc Med 2022;9:897106. [DOI: 10.3389/fcvm.2022.897106] [Reference Citation Analysis]
9 Surówka A, Szumilas K, Wilk A, Misiakiewicz-Has K, Ciechanowski K, Kędzierska-Kapuza K. The Effect of Chronic Immunosuppressive Regimens Treatment on Aortal Media Morphology and the Balance between Matrix Metalloproteinases (mmp-2 and mmp-9) and Their Inhibitors in the Abdominal Aorta of Rats. Int J Environ Res Public Health 2022;19:6399. [PMID: 35681984 DOI: 10.3390/ijerph19116399] [Reference Citation Analysis]
10 Caimi G, Urso C, Brucculeri S, Amato C, Presti RL, Carlisi M. Leukocyte subtypes, gelatinases, and their tissue inhibitors in a group of subjects with asymptomatic carotid atherosclerosis. CH 2022. [DOI: 10.3233/ch-221380] [Reference Citation Analysis]
11 Li D, Ma Y, Deng W, Feng J, Yu G. Construction and Analysis of lncRNA-Associated ceRNA Network in Atherosclerotic Plaque Formation. BioMed Research International 2022;2022:1-12. [DOI: 10.1155/2022/4895611] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Pogorielova OS, Korniienko VV, Chumachenko YD, Obukhova OA, Martsovenko I, Harbuzova VY, Sun J. Impact of MMP-9 Genetic Polymorphism and Concentration on the Development of Coronary Artery Disease in Ukrainian Population. Cardiology Research and Practice 2022;2022:1-8. [DOI: 10.1155/2022/2067632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Yurdagul A Jr. Crosstalk Between Macrophages and Vascular Smooth Muscle Cells in Atherosclerotic Plaque Stability. Arterioscler Thromb Vasc Biol 2022;42:372-80. [PMID: 35172605 DOI: 10.1161/ATVBAHA.121.316233] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
14 Bellomo TR, Bone WP, Chen BY, Gawronski KAB, Zhang D, Park J, Levin M, Tsao N, Klarin D, Lynch J, Assimes TL, Gaziano JM, Wilson PW, Cho K, Vujkovic M, O'Donnell CJ, Chang KM, Tsao PS, Rader DJ, Ritchie MD, Damrauer SM, Voight BF. Multi-Trait Genome-Wide Association Study of Atherosclerosis Detects Novel Pleiotropic Loci. Front Genet 2021;12:787545. [PMID: 35186008 DOI: 10.3389/fgene.2021.787545] [Reference Citation Analysis]
15 Su X, Gao Y, Xu W, Li J, Chen K, Gao Y, Guo J, Zhao L, Wang H, Qian X, Lin J, Han J, Liu L. Association Cystatin C and Risk of Stroke in Elderly Patients With Obstructive Sleep Apnea: A Prospective Cohort Study. Front Neurosci 2021;15:762552. [PMID: 34975375 DOI: 10.3389/fnins.2021.762552] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Petković A, Erceg S, Munjas J, Ninić A, Sopić M. Circulating non-coding RNAs as biomarkers in coronary artery disease. Arhiv za farmaciju 2022;72:149-165. [DOI: 10.5937/arhfarm72-36166] [Reference Citation Analysis]
17 Opincariu D, Rodean I, Rat N, Hodas R, Benedek I, Benedek T. Systemic Vulnerability, as Expressed by I-CAM and MMP-9 at Presentation, Predicts One Year Outcomes in Patients with Acute Myocardial Infarction-Insights from the VIP Clinical Study. J Clin Med 2021;10:3435. [PMID: 34362217 DOI: 10.3390/jcm10153435] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
18 Qian C, Jing Y, Xia M, Ye Q. Comprehensive analysis of dysregulated genes associated with atherosclerotic plaque destabilization. Exp Biol Med (Maywood) 2021;:15353702211033247. [PMID: 34308657 DOI: 10.1177/15353702211033247] [Reference Citation Analysis]
19 Kowara M, Cudnoch-Jedrzejewska A. Different Approaches in Therapy Aiming to Stabilize an Unstable Atherosclerotic Plaque. Int J Mol Sci 2021;22:4354. [PMID: 33919446 DOI: 10.3390/ijms22094354] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
20 Opincariu D, Rat N, Benedek I. The Role of Matrix Metalloproteinases in the Progression and Vulnerabilization of Coronary Atherosclerotic Plaques. Journal Of Cardiovascular Emergencies 2021;7:9-16. [DOI: 10.2478/jce-2021-0001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Shiber S, Kliminski V, Orvin K, Sagy I, Vaturi M, Kornowski R, Drescher M, Molad Y. Elevated Plasma Soluble Triggering Receptor Expressed on Myeloid Cells-1 Level in Patients with Acute Coronary Syndrome (ACS): A Biomarker of Disease Severity and Outcome. Mediators Inflamm 2021;2021:8872686. [PMID: 33814983 DOI: 10.1155/2021/8872686] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]